ReviewCurrent pharmacology reports2022

Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach.

Rajan Rolta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.